The research focused on reactive astrogliosis, a process involving changes in brain cells called astrocytes. These changes are believed to play a significant role in the progression of Parkinson's ...

(OTC: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease by blocking astrogliosis and ...